T-cell receptor recognizing the P30 tetanus toxin epitope (TCR-P30)

The CD4+ T cell receptor (TCR) recognizing the P30 helper epitope is a specialized immune receptor that identifies a specific peptide sequence (FNNFTVSFWLRVPKVSASHLE) derived from the tetanus toxin (Panina-Bordignon et al., 1989, Eur. J. Immunol.). The P30 epitope is widely recognized as a universal or promiscuous T-cell epitope because it can be presented by a broad array of Human Leukocyte Antigen (HLA) Class II molecules, ensuring recognition across a diverse human population (Demotz et al., 1989, J. Immunol.). When this TCR binds to the P30 peptide-MHC complex, it triggers the activation of CD4+ T helper cells, which subsequently release cytokines like IFN-gamma and IL-2 to support B-cell maturation and CD8+ T-cell activity (Reece et al., 1994, Immunol. Cell Biol.). In clinical development, the P30 epitope is frequently utilized as a molecular adjuvant or carrier protein component in conjugate vaccines to enhance the immunogenicity of otherwise weak antigens, such as those used in cancer immunotherapy or vaccines against small molecules like nicotine (Valmori et al., 1992, J. Immunol.). By leveraging the high frequency of P30-reactive T cells in the general population—often due to prior tetanus vaccination—drugs and vaccines targeting this TCR interaction can achieve potent and predictable immune responses.

Other names

P30-specific T-cell receptorTetanus toxin P30 epitope-specific TCRCD4+ TCR for P30 helper epitopeUniversal helper T-cell receptor

Activation of CD4+ T helper cells through the recognition of the P30 peptide presented on MHC Class II molecules, facilitating B-cell help and antibody production.